TipRanks
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
ASX:IMR
Australian Market
IMR
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
RESEARCH TOOLSreports
Want to see AU:IMR full AI Analyst Report?

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR) Ratios

11 Followers

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Ratios

AU:IMR's free cash flow for Q2 2026 was $-55.59. For the 2026 fiscal year, AU:IMR's free cash flow was decreased by $ and operating cash flow was $-638.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.72 2.47 7.79 0.86 4.67
Quick Ratio
 1.68 2.41 7.15 0.49 3.57
Cash Ratio
 1.49 1.12 6.67 0.18 2.74
Solvency Ratio
 -0.82 -0.73 -1.00 -1.28 -2.72
Operating Cash Flow Ratio
 -0.59 -1.14 -6.61 -2.84 -8.11
Short-Term Operating Cash Flow Coverage
 -0.72 -1.68 -74.47 -35.58 0.00
Net Current Asset Value
$ 25.17M$ 8.69M$ -10.65M$ -13.12M$ 3.49M
Leverage Ratios
Debt-to-Assets Ratio
 0.46 0.57 0.99 1.25 0.32
Debt-to-Equity Ratio
 1.17 2.25 -2.89 -0.81 0.59
Debt-to-Capital Ratio
 0.54 0.69 1.53 -4.33 0.37
Long-Term Debt-to-Capital Ratio
 0.00 0.54 1.58 -2.05 0.23
Financial Leverage Ratio
 2.53 3.97 -2.93 -0.65 1.82
Debt Service Coverage Ratio
 -0.81 -1.92 -67.84 -52.99 -92.55
Interest Coverage Ratio
 0.00 -5.47K -812.20 -351.53 -96.55
Debt to Market Cap
 0.10 0.08 0.11 0.16 0.06
Interest Debt Per Share
 0.11 0.08 0.10 0.07 0.03
Net Debt to EBITDA
 0.99 -0.29 -0.36 -0.44 0.08
Profitability Margins
Gross Profit Margin
-2310.42%-695.68%-96.32%-181.27%-187.10%
EBIT Margin
-22678.23%-7796.89%-1698.60%-3667.82%-2105.16%
EBITDA Margin
-21960.35%-7456.40%-1620.62%-3552.88%-2017.85%
Operating Profit Margin
-22678.23%-7796.89%-1698.60%-2738.12%-2105.16%
Pretax Profit Margin
-30813.40%-8661.59%-3094.86%-3675.61%-2126.96%
Net Profit Margin
-30813.40%-8661.59%-3094.86%-3675.61%-2148.77%
Continuous Operations Profit Margin
-30813.40%-8661.59%-3094.86%-3675.61%-2126.96%
Net Income Per EBT
100.00%100.00%100.00%100.00%101.03%
EBT Per EBIT
135.87%111.09%182.20%134.24%101.04%
Return on Assets (ROA)
-51.01%-57.22%-137.31%-272.33%-127.98%
Return on Equity (ROE)
-184.93%-227.22%402.50%176.38%-233.46%
Return on Capital Employed (ROCE)
-83.73%-83.03%-84.58%-450.67%-147.76%
Return on Invested Capital (ROIC)
-41.55%-58.28%-82.57%-382.38%-137.50%
Return on Tangible Assets
-51.01%-57.22%-137.31%-272.33%-127.98%
Earnings Yield
-11.12%-8.31%-15.75%-39.77%-48.37%
Efficiency Ratios
Receivables Turnover
 0.48 1.26 2.78 1.57 6.50
Payables Turnover
 2.47 4.85 5.62 0.82 9.04
Inventory Turnover
 2.18 2.19 1.25 1.03 1.03
Fixed Asset Turnover
 0.05 0.14 0.37 0.19 0.23
Asset Turnover
 <0.01 <0.01 0.04 0.07 0.06
Working Capital Turnover Ratio
 <0.01 0.01 0.12 0.18 0.06
Cash Conversion Cycle
 782.24 381.87 357.56 143.64 370.47
Days of Sales Outstanding
 762.82 290.83 131.38 232.77 56.16
Days of Inventory Outstanding
 167.27 166.32 291.07 354.45 354.71
Days of Payables Outstanding
 147.85 75.28 64.89 443.58 40.39
Operating Cycle
 930.09 457.15 422.45 587.21 410.86
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.08 -0.06 -0.07 -0.08 -0.11
Free Cash Flow Per Share
 -0.08 -0.07 -0.07 -0.08 -0.11
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.03 1.02 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 -30.04 -43.94 -199.73 -156.76 -70.43
Capital Expenditure Coverage Ratio
 -30.04 -43.94 -199.73 -156.76 -70.43
Operating Cash Flow Coverage Ratio
 -0.70 -0.76 -0.73 -1.25 -3.78
Operating Cash Flow to Sales Ratio
 -195.95 -65.28 -16.23 -21.08 -20.61
Free Cash Flow Yield
-7.15%-6.41%-8.30%-22.96%-47.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -9.31 -11.78 -6.48 -2.51 -2.07
Price-to-Sales (P/S) Ratio
 2.81K 1.04K 196.53 92.43 44.43
Price-to-Book (P/B) Ratio
 11.53 27.34 -25.56 -4.44 4.83
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.88 -15.61 -12.05 -4.36 -2.12
Price-to-Operating Cash Flow Ratio
 -14.04 -15.96 -12.11 -4.38 -2.16
Price-to-Earnings Growth (PEG) Ratio
 0.13 0.35 0.91 -0.15 0.10
Price-to-Fair Value
 11.53 27.34 -25.56 -4.44 4.83
Enterprise Value Multiple
 -11.81 -14.26 -12.49 -3.04 -2.13
Enterprise Value
 318.26M 321.67M 194.19M 66.48M 35.01M
EV to EBITDA
 -11.90 -14.26 -12.49 -3.04 -2.13
EV to Sales
 2.61K 1.06K 202.41 108.00 42.90
EV to Free Cash Flow
 -12.90 -15.93 -12.41 -5.09 -2.05
EV to Operating Cash Flow
 -13.33 -16.29 -12.47 -5.12 -2.08
Tangible Book Value Per Share
 0.09 0.04 -0.03 -0.06 0.05
Shareholders’ Equity Per Share
 0.09 0.04 -0.03 -0.08 0.05
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.12 -0.08 -0.13 -0.14 -0.12
Tax Burden
 1.00 1.00 1.00 1.00 1.01
Interest Burden
 1.36 1.11 1.82 1.00 1.01
Research & Development to Revenue
 108.58 38.16 8.53 12.87 9.74
SG&A to Revenue
 95.10 31.74 7.50 8.27 6.11
Stock-Based Compensation to Revenue
 9.01 0.00 0.00 0.00 0.00
Income Quality
 0.64 0.75 0.52 0.57 0.96
Currency in USD